Designing Clinically Important Medical Devices
DEVELOPED BY DOCTORS FOR DOCTORS
THE NEW TOOL FOR DRUG EFFICACY
Delivering innovative diagnostic cancer tests
Facebook
Twitter
Linkedin
About Us
Our Mission
Technology
Management
Scientific Advisory Board
Medical Advisory Board
Press Releases
Our Products
Publications
Publication
Scientific Posters
Contact
About
chornixadm
This author has not yet filled in any details.
So far chornixadm has created 66 blog entries.
Oellerich M et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. Ther Drug Monit. 2014 Apr;36(2):136-40
By
chornixadm
|
2018-09-27T11:02:37+00:00
September 27th, 2018
|
Medical publications
,
Transplant
|
0 Comments
Read More
Schütz E et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Med (2017) 14: e1002286
By
chornixadm
|
2018-09-27T10:53:49+00:00
September 27th, 2018
|
Medical publications
,
Transplant
|
0 Comments
Read More
Beck J et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem. 2013 Dec;59(12):1732-41
By
chornixadm
|
2018-09-27T10:49:49+00:00
September 27th, 2018
|
Medical publications
,
Transplant
|
0 Comments
Read More
Kanzow P et al. Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver. Transplantation. 2014 Sep 15;98(5):e43-5
By
chornixadm
|
2018-09-27T10:43:04+00:00
September 27th, 2018
|
Medical publications
,
Transplant
|
0 Comments
Read More
Oellerich M et al. Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury. Ther Drug Monit. 2016 Apr;38 Suppl 1:S75-9
By
chornixadm
|
2018-09-27T10:41:03+00:00
September 27th, 2018
|
Medical publications
,
Transplant
|
0 Comments
Read More
Beck J, et al. Profile of the circulating DNA in apparently healthy individuals. Clin Chem. 2009 Apr;55(4):730-8
By
chornixadm
|
2018-09-27T10:21:05+00:00
September 27th, 2018
|
Cancer
,
Medical publications
|
0 Comments
Read More
Beck J et al. Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA. PLoS One. 2013 Sep 30;8(9):e75485
By
chornixadm
|
2018-09-27T10:19:10+00:00
September 27th, 2018
|
Cancer
,
Medical publications
|
0 Comments
Read More
Oellerich M et al. Using Circulating Cell-free DNA to Monitor Personalized Cancer Therapy. Crit. Rev. Clin. Lab. Sci 2017; 54:205-218
By
chornixadm
|
2018-09-27T10:13:54+00:00
September 27th, 2018
|
Cancer
,
Medical publications
|
0 Comments
Read More
Beck J et al. Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res. 2010 Mar;8(3):335-42.
By
chornixadm
|
2018-09-27T10:11:24+00:00
September 27th, 2018
|
Cancer
,
Medical publications
|
0 Comments
Read More
Schütz E et al. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clin Chem. 2015 Jan;61(1):239-48
By
chornixadm
|
2018-09-27T10:07:57+00:00
September 27th, 2018
|
Cancer
,
Medical publications
|
0 Comments
Read More
Previous
1
2
3
4
Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
Read more
